NCT02031432
- Conditions
- Cancer Pain, Chronic Pain, Neoplasms, +4 more
- Locations
-
- AT004 Vienna, Austria
- BE001 Sint-Niklaas, Belgium
- BG001 Shumen, Bulgaria
- BG008 Sofia, Bulgaria
Clinical trial condition
Neoplasms
Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.
818 public trials
114 recruiting studies
Neoplasms trial results
NCT03351140
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
- GSK Investigational Site Mountlake Terrace, Washington, United States
NCT02696642
- Conditions
- Neoplasms
- Locations
-
- Caen, France
- Dijon, France
- Lille, France
- Lyon, France
NCT03092934
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +18 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Jewish General Hospital Montreal, Quebec, Canada
- McGill University Montreal, Quebec, Canada
NCT01343043
- Conditions
- Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +5 more
- Locations
-
- GSK Investigational Site Duarte, California, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site Tampa, Florida, United States
- GSK Investigational Site Bethesda, Maryland, United States
NCT01789281
- Conditions
- Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
- Locations
-
- Hematology Oncology Services of Arkansas SC Little Rock, Arkansas, United States
- Rocky Mountain Cancer Centers SC Greenwood Village, Colorado, United States
- Stamford Hospital Stamford, Connecticut, United States
- H Lee Moffitt Cancer Center and Research Institute SC-2 Tampa, Florida, United States
Completed
Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment Patients
NCT03359850
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Newport Beach, California, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Atlanta, Georgia, United States
Completed
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
NCT02528357
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Nashville, Tennessee, United States
NCT01976741
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +21 more
- Locations
-
- Chicago, Illinois, United States
- Chicago, Illinois, United States
- Pittsburgh, Pennsylvania, United States
- Besançon, France
- Conditions
- Bone Diseases, Bone Neoplasm, Bone Neoplasms, +6 more
- Locations
-
- The Ohio State University Columbus, Ohio, United States